AI Insight: Cardinal Health's current price sits 22.7% below the PERT-weighted fair value, indicating potential undervaluation amid high-confidence valuation methods. Financial health shows weak profitability and growth but strong leverage, implying elevated financial risk. Monte Carlo analysis reveals high volatility with a significant downside risk of 36.1% below current price, highlighting uncertainty in value realization.